Cargando…

A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma

BACKGROUND: Abundant collagen deposition is a hallmark of pancreatic ductal adenocarcinomas (PDACs). This study clarified the interactive relationship between tumor-stromal collagen, molecular and immune characteristics, and tumor pr ogression in human PDAC. METHODS: We performed a comprehensive exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashina, Shigeto, Masuda, Atsuhiro, Yamakawa, Kohei, Hamada, Tsuyoshi, Tsujimae, Masahiro, Tanaka, Takeshi, Toyama, Hirochika, Sofue, Keitaro, Shiomi, Hideyuki, Sakai, Arata, Kobayashi, Takashi, Abe, Shohei, Gonda, Masanori, Masuda, Shigeto, Inomata, Noriko, Uemura, Hisahiro, Kohashi, Shinya, Nagao, Kae, Harada, Yoshiyuki, Miki, Mika, Juri, Noriko, Irie, Yosuke, Kanzawa, Maki, Itoh, Tomoo, Inoue, Jun, Imai, Toshio, Fukumoto, Takumi, Kodama, Yuzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522520/
https://www.ncbi.nlm.nih.gov/pubmed/37477731
http://dx.doi.org/10.1007/s00535-023-02020-8
_version_ 1785110372991107072
author Ashina, Shigeto
Masuda, Atsuhiro
Yamakawa, Kohei
Hamada, Tsuyoshi
Tsujimae, Masahiro
Tanaka, Takeshi
Toyama, Hirochika
Sofue, Keitaro
Shiomi, Hideyuki
Sakai, Arata
Kobayashi, Takashi
Abe, Shohei
Gonda, Masanori
Masuda, Shigeto
Inomata, Noriko
Uemura, Hisahiro
Kohashi, Shinya
Nagao, Kae
Harada, Yoshiyuki
Miki, Mika
Juri, Noriko
Irie, Yosuke
Kanzawa, Maki
Itoh, Tomoo
Inoue, Jun
Imai, Toshio
Fukumoto, Takumi
Kodama, Yuzo
author_facet Ashina, Shigeto
Masuda, Atsuhiro
Yamakawa, Kohei
Hamada, Tsuyoshi
Tsujimae, Masahiro
Tanaka, Takeshi
Toyama, Hirochika
Sofue, Keitaro
Shiomi, Hideyuki
Sakai, Arata
Kobayashi, Takashi
Abe, Shohei
Gonda, Masanori
Masuda, Shigeto
Inomata, Noriko
Uemura, Hisahiro
Kohashi, Shinya
Nagao, Kae
Harada, Yoshiyuki
Miki, Mika
Juri, Noriko
Irie, Yosuke
Kanzawa, Maki
Itoh, Tomoo
Inoue, Jun
Imai, Toshio
Fukumoto, Takumi
Kodama, Yuzo
author_sort Ashina, Shigeto
collection PubMed
description BACKGROUND: Abundant collagen deposition is a hallmark of pancreatic ductal adenocarcinomas (PDACs). This study clarified the interactive relationship between tumor-stromal collagen, molecular and immune characteristics, and tumor pr ogression in human PDAC. METHODS: We performed a comprehensive examination using an integrative molecular pathological epidemiology database on 169 cases with resected PDAC . The amount of tumor-stromal collagen was quantified through digital imaging analysis for Elastica van Gieson-stained whole-section tumor slides. We analyzed the association of tumor-stromal collagen with gene alterations (KRAS, TP53, CDKN2A/p16, and SMAD4), immune parameters (CD4(+) tumor-infiltrating lymphocytes [TILs], CD8(+) TILs, FOXP3(+) TILs, and tertiary lymphoid structures), and patient prognosis. RESULTS: Low amounts of tumor-stromal collagen were associated with poor differentiation (multivariable OR = 3.82, 95%CI = 1.41–12.2, P = 0.008) and CDKN2A/p16 alteration (OR [95%CI] = 2.06 [1.08–4.02], P = 0.03). Tumors with low collagen levels had shorter overall survival (HR [95%CI] = 2.38 [1.59–3.56], P < 0.0001). In the S-1 and gemcitabine (GEM) treatment groups, low tumor-stromal collagen was linked to poor prognosis of patients with PDAC (S-1 group: multivariable HR [95%CI] = 2.76 [1.36–5.79], P = 0.005; GEM group: multivariate HR [95%CI] = 2.91 [1.34–6.71], P = 0.007). Additionally, low amounts of tumor-stromal collagen were also linked to low levels of CD4(+) TILs (P = 0.046), CD8(+) TILs (P = 0.09), and tertiary lymphoid structures (P = 0.001). CONCLUSIONS: Tumor-stromal collagen deposition may play a crucial role in modulating tumor-immune microenvironment and determining response to adjuvant chemotherapy and patient survival outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00535-023-02020-8.
format Online
Article
Text
id pubmed-10522520
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-105225202023-09-28 A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma Ashina, Shigeto Masuda, Atsuhiro Yamakawa, Kohei Hamada, Tsuyoshi Tsujimae, Masahiro Tanaka, Takeshi Toyama, Hirochika Sofue, Keitaro Shiomi, Hideyuki Sakai, Arata Kobayashi, Takashi Abe, Shohei Gonda, Masanori Masuda, Shigeto Inomata, Noriko Uemura, Hisahiro Kohashi, Shinya Nagao, Kae Harada, Yoshiyuki Miki, Mika Juri, Noriko Irie, Yosuke Kanzawa, Maki Itoh, Tomoo Inoue, Jun Imai, Toshio Fukumoto, Takumi Kodama, Yuzo J Gastroenterol Original Article―Liver, Pancreas, and Biliary Tract BACKGROUND: Abundant collagen deposition is a hallmark of pancreatic ductal adenocarcinomas (PDACs). This study clarified the interactive relationship between tumor-stromal collagen, molecular and immune characteristics, and tumor pr ogression in human PDAC. METHODS: We performed a comprehensive examination using an integrative molecular pathological epidemiology database on 169 cases with resected PDAC . The amount of tumor-stromal collagen was quantified through digital imaging analysis for Elastica van Gieson-stained whole-section tumor slides. We analyzed the association of tumor-stromal collagen with gene alterations (KRAS, TP53, CDKN2A/p16, and SMAD4), immune parameters (CD4(+) tumor-infiltrating lymphocytes [TILs], CD8(+) TILs, FOXP3(+) TILs, and tertiary lymphoid structures), and patient prognosis. RESULTS: Low amounts of tumor-stromal collagen were associated with poor differentiation (multivariable OR = 3.82, 95%CI = 1.41–12.2, P = 0.008) and CDKN2A/p16 alteration (OR [95%CI] = 2.06 [1.08–4.02], P = 0.03). Tumors with low collagen levels had shorter overall survival (HR [95%CI] = 2.38 [1.59–3.56], P < 0.0001). In the S-1 and gemcitabine (GEM) treatment groups, low tumor-stromal collagen was linked to poor prognosis of patients with PDAC (S-1 group: multivariable HR [95%CI] = 2.76 [1.36–5.79], P = 0.005; GEM group: multivariate HR [95%CI] = 2.91 [1.34–6.71], P = 0.007). Additionally, low amounts of tumor-stromal collagen were also linked to low levels of CD4(+) TILs (P = 0.046), CD8(+) TILs (P = 0.09), and tertiary lymphoid structures (P = 0.001). CONCLUSIONS: Tumor-stromal collagen deposition may play a crucial role in modulating tumor-immune microenvironment and determining response to adjuvant chemotherapy and patient survival outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00535-023-02020-8. Springer Nature Singapore 2023-07-21 2023 /pmc/articles/PMC10522520/ /pubmed/37477731 http://dx.doi.org/10.1007/s00535-023-02020-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article―Liver, Pancreas, and Biliary Tract
Ashina, Shigeto
Masuda, Atsuhiro
Yamakawa, Kohei
Hamada, Tsuyoshi
Tsujimae, Masahiro
Tanaka, Takeshi
Toyama, Hirochika
Sofue, Keitaro
Shiomi, Hideyuki
Sakai, Arata
Kobayashi, Takashi
Abe, Shohei
Gonda, Masanori
Masuda, Shigeto
Inomata, Noriko
Uemura, Hisahiro
Kohashi, Shinya
Nagao, Kae
Harada, Yoshiyuki
Miki, Mika
Juri, Noriko
Irie, Yosuke
Kanzawa, Maki
Itoh, Tomoo
Inoue, Jun
Imai, Toshio
Fukumoto, Takumi
Kodama, Yuzo
A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
title A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
title_full A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
title_fullStr A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
title_full_unstemmed A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
title_short A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
title_sort comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
topic Original Article―Liver, Pancreas, and Biliary Tract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522520/
https://www.ncbi.nlm.nih.gov/pubmed/37477731
http://dx.doi.org/10.1007/s00535-023-02020-8
work_keys_str_mv AT ashinashigeto acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT masudaatsuhiro acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT yamakawakohei acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT hamadatsuyoshi acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT tsujimaemasahiro acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT tanakatakeshi acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT toyamahirochika acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT sofuekeitaro acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT shiomihideyuki acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT sakaiarata acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT kobayashitakashi acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT abeshohei acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT gondamasanori acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT masudashigeto acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT inomatanoriko acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT uemurahisahiro acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT kohashishinya acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT nagaokae acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT haradayoshiyuki acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT mikimika acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT jurinoriko acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT irieyosuke acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT kanzawamaki acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT itohtomoo acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT inouejun acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT imaitoshio acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT fukumototakumi acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT kodamayuzo acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT ashinashigeto comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT masudaatsuhiro comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT yamakawakohei comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT hamadatsuyoshi comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT tsujimaemasahiro comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT tanakatakeshi comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT toyamahirochika comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT sofuekeitaro comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT shiomihideyuki comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT sakaiarata comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT kobayashitakashi comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT abeshohei comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT gondamasanori comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT masudashigeto comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT inomatanoriko comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT uemurahisahiro comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT kohashishinya comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT nagaokae comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT haradayoshiyuki comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT mikimika comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT jurinoriko comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT irieyosuke comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT kanzawamaki comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT itohtomoo comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT inouejun comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT imaitoshio comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT fukumototakumi comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma
AT kodamayuzo comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma